Satoshi Ushijima

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan

Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka et al. · Annals of the Rheumatic Diseases · 2019 · 130 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)

Yoshiya Tanaka, Tsutomu Takeuchi, Sakae Tanaka et al. · Annals of the Rheumatic Diseases · 2019 · 108 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Endovascular Stent-Grafting for Infected Iliac Artery Pseudoaneurysms

Junichiro Sanada, Osamu Matsui, Fumitaka Arakawa et al. · CardioVascular and Interventional Radiology · 2004 · 59 citations

Medicine, Orthopedic Surgery, Surgery +10

A Long-Term Study of Acotiamide in Patients with Functional Dyspepsia: Results from an Open-Label Phase III Trial in Japan on Efficacy, Safety and Pattern of Administration

Kei Matsueda, Michio Hongo, Satoshi Ushijima et al. · Digestion · 2011 · 49 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan

Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka et al. · Arthritis Research & Therapy · 2020 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14